| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2020.06.496 |
| P698 | PubMed publication ID | 32680634 |
| P2093 | author name string | A Goodman | |
| Jannatul Ferdous | |||
| Rifat Ara | |||
| Shirin Akter Begum | |||
| Munira Jahan | |||
| Sabera Khatun | |||
| Monowara Begum | |||
| Sayada Fatema | |||
| Shahana Nazneen | |||
| Shahana Pervin | |||
| Umme Shahera | |||
| P2860 | cites work | HPV testing as a screen for cervical cancer | Q26828562 |
| Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts | Q27023127 | ||
| Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china | Q30278596 | ||
| Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study | Q30307042 | ||
| Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer | Q34046296 | ||
| Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer | Q34433015 | ||
| Lower cost strategies for triage of human papillomavirus DNA-positive women | Q34516596 | ||
| HPV screening for cervical cancer in rural India | Q34973414 | ||
| Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions | Q34995358 | ||
| A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia | Q36169189 | ||
| Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia | Q37302072 | ||
| Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. | Q37451826 | ||
| World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer | Q40915197 | ||
| An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China | Q42282083 | ||
| Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA | Q43820576 | ||
| A magnetic immunochromatographic strip test for detection of human papillomavirus 16 E6. | Q44232115 | ||
| Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening | Q44876752 | ||
| Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer. | Q48263482 | ||
| HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway. | Q51760001 | ||
| HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. | Q51824401 | ||
| Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. | Q53028990 | ||
| Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6. | Q53288169 | ||
| Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. | Q53304855 | ||
| Overview of the European and North American studies on HPV testing in primary cervical cancer screening | Q57414808 | ||
| Prevalence of human papilloma virus with risk of cervical cancer among south Indian women: A genotypic study with meta-analysis and molecular dynamics of HPV E6 oncoprotein | Q59349199 | ||
| Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial | Q61626075 | ||
| Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting | Q81306581 | ||
| Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 | ||
| Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results | Q84554685 | ||
| Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study | Q84818275 | ||
| Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women | Q89254600 | ||
| Spontaneous Regression of Cervical Intraepithelial Neoplasia 2: A Meta-analysis | Q91764271 | ||
| P921 | main subject | biomarker | Q864574 |
| human papilloma virus | Q69999790 | ||
| P577 | publication date | 2020-07-14 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening |
Search more.